In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 36 for your search:
Drug:  plerixafor
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 78
Sponsor: Other
Protocol IDs: MOZ11809, MSC12830, NCT01164475

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 78
Sponsor: Other
Protocol IDs: AMD3100-3101, FHCRC-1985.00, NCT00103610

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 78
Sponsor: Other
Protocol IDs: AMD3100-3102, 2005-003599-39, FHCRC-1986.00, NCT00103662

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: MOZ00808, 2008-000689-21, NCT00838357

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 03-0349, NCT00241358

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 08-0897 / 201105349, NCT00733824

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0227 / 201011796, NCT00512252

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: 2007-0772, NCT00822770

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 10-0910 / 201106039, NCT00906945

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Other
Protocol IDs: 2009-0536, NCI-2012-01786, NCT01160354

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 60
Sponsor: Other
Protocol IDs: SPON 845-10, 2010-021444-18, 10/MRE09/27, NCT01236144

12.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 09174, NCI-2011-00344, P50 CA107399, NCT01318317

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: AMD3100-C201, NCT00396266

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 78
Sponsor: Other
Protocol IDs: AMD31002112, NCT00396331

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: AMD31002113, NCT00444912

16.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 to 78
Sponsor: Other
Protocol IDs: AMD3100-EU23, EudraCT number: 2006-00424729, NCT00665314

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: Pro00014563, NCT00901225

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 09-0713 / 201103429, NCT00914849

19.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MC0889, NCI-2009-01328, 08-005644, NCT00998049

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CCM-002, NCT01037517

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2310.00, NCI-2009-01562, 7157, P30CA015704, NCT01097057

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 10-1154 / 201108083, NCT01158118

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: SHEBA-09-7481-AN-CTIL, NCT01164345

24.

Phase: Phase II
Type: Health services research, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 236/09, 2010DR2052, 10-CPRS-001, 1795, NCT01220375

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 0 to 18
Sponsor: Other
Protocol IDs: CHU-0082, NCT01225419
1   
New Search